| 1 |
Bayer Intellectual Property GmbH et al v. Breckenridge Pharmaceutical, Inc. |
1:17-cv-01129 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 2 |
Bayer Intellectual Property GmbH et al v. Breckenridge Pharmaceutical, Inc. |
1:17-cv-01129 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 3 |
Bayer Intellectual Property GmbH et al v. Breckenridge Pharmaceutical, Inc. |
1:17-cv-01129 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 4 |
CELGENE CORPORATION v. HETERO LABS LIMITED et al |
2:17-cv-03387 |
D.N.J. |
|
|
|
|
| 5 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 6 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 7 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 8 |
Sanofi-Aventis U.S. LLC et al v. Breckenridge Pharmaceutical, Inc. |
1:17-cv-00019 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 9 |
Sanofi-Aventis U.S. LLC et al v. Breckenridge Pharmaceutical, Inc. |
1:17-cv-00019 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 10 |
Sanofi-Aventis U.S. LLC et al v. Breckenridge Pharmaceutical, Inc. |
1:17-cv-00019 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 11 |
Sanofi-Aventis U.S. LLC et al v. Breckenridge Pharmaceutical, Inc. |
1:17-cv-00019 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 12 |
OTSUKA PHARMACEUTICAL CO., LTD. v. STASON INDUSTRIAL CORP. et al |
1:16-cv-00557 |
D.N.J. |
|
|
|
|
| 13 |
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc. |
1:15-cv-01039 |
D.Del. |
|
|
|
|
| 14 |
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc. |
1:15-cv-01039 |
D.Del. |
|
|
|
|
| 15 |
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc. et al |
1:15-cv-00486 |
D.Del. |
|
|
|
|
| 16 |
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc. et al |
1:15-cv-00486 |
D.Del. |
|
|
|
|
| 17 |
SANOFI-AVENTIS U.S. LLC et al v. BRECKENRIDGE PHARMACEUTICAL, INC. |
3:15-cv-01836 |
D.N.J. |
|
|
|
|
| 18 |
SANOFI-AVENTIS U.S. LLC et al v. BRECKENRIDGE PHARMACEUTICAL, INC. |
3:15-cv-01836 |
D.N.J. |
|
|
|
|
| 19 |
SANOFI-AVENTIS U.S. LLC et al v. BRECKENRIDGE PHARMACEUTICAL, INC. |
3:15-cv-01836 |
D.N.J. |
|
|
|
|
| 20 |
Forest Laboratories LLC et al v. Sigmapharm Laboratories LLC et al |
1:14-cv-01119 |
D.Del. |
|
|
|
|
| 21 |
Forest Laboratories LLC et al v. Sigmapharm Laboratories LLC et al |
1:14-cv-01119 |
D.Del. |
|
|
|
|
| 22 |
Novartis Pharmaceuticals Corporation et al v. Breckenridge Pharmaceutical, Inc. |
1:14-cv-05729 |
S.D.N.Y. |
|
|
|
|
| 23 |
Novartis Pharmaceuticals Corporation et al v. Breckenridge Pharmaceutical, Inc. |
1:14-cv-05729 |
S.D.N.Y. |
|
|
|
|
| 24 |
Novartis Pharmaceuticals Corporation et al v. Breckenridge Pharmaceutical, Inc. |
1:14-cv-05729 |
S.D.N.Y. |
|
|
|
|
| 25 |
Braintree Laboratories, Inc. v. Cypress Pharmaceutical, Inc. |
1:12-cv-06851 |
S.D.N.Y. |
|
|
|
|
| 26 |
BRADLEY PHARMACEUTICALS, INC. v. BRECKENRIDGE PHARMACEUTICALS, INC. |
2:06-cv-02442 |
D.N.J. |
|
|
|
|
| 27 |
Breckenridge Pharmaceutical, Inc. v. Metabolite Laboratories, Inc. |
1:05-cv-01083 |
D.Colo. |
|
|
|
|